lecture 12, concept 29: lead optimization for the hiv-1 protease inhibitor
Published 3 years ago • 2.3K plays • Length 3:16
Download video MP4
Download video MP3
Similar videos
-
2:35
lecture 12, concept 28: improving affinity - lead optimization
-
6:37
lecture 12, concept 11: from preclinical through phase i, ii, & iii trials to regulatory approval
-
2:03
lecture 12, concept 03: from biology to target proteins to binding sites
-
0:19
what is the benefit of darunavir versus other hiv medications?
-
5:34
covid19 final call • estimation study on hiv/hepc protease inhibitors (11)
-
14:47
pharmacology - hiv antiretroviral drugs (classes, mechanism of action and side effects)
-
28:59
discovery of 3cl protease inhibitor by dr michael levitt
-
27:39
fireside chat: immuno-oncology
-
3:33
lecture 13, concept 06: allosteric modulation of igand-gated ion channels with different drugs
-
30:09
j. andrew mccammon - national biomedical computation resource summer institute 2009
-
33:24
ias 2019 in the studio - episode two
-
42:41
cholesterol basics webinar
-
11:48
protease inhibitor treatment for hiv/aids
-
8:45
hiv update series - part 4 of 7 - drug classes
-
11:55
basic science of integrase inhibitors | mark wainberg, md
-
51:10
cgt4hivcure 2015: day 2, session 9 - therapeutic development & gene therapy, closing remarks
-
2:38
optimizing outcomes with pre- and post-transplant interventions
Clip.africa.com - Privacy-policy